{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T16:43:10Z","timestamp":1788021790893,"version":"build-2784847793"},"reference-count":67,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,9,5]],"date-time":"2020-09-05T00:00:00Z","timestamp":1599264000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,9,5]],"date-time":"2020-09-05T00:00:00Z","timestamp":1599264000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003399","name":"Science and Technology Commission of Shanghai Municipality","doi-asserted-by":"publisher","award":["19PJ1408600"],"award-info":[{"award-number":["19PJ1408600"]}],"id":[{"id":"10.13039\/501100003399","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003399","name":"Science and Technology Commission of Shanghai Municipality","doi-asserted-by":"publisher","award":["18142202100"],"award-info":[{"award-number":["18142202100"]}],"id":[{"id":"10.13039\/501100003399","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003399","name":"Science and Technology Commission of Shanghai Municipality","doi-asserted-by":"publisher","award":["17JC1400804"],"award-info":[{"award-number":["17JC1400804"]}],"id":[{"id":"10.13039\/501100003399","id-type":"DOI","asserted-by":"publisher"}]},{"name":"CAS Key Laboratory of Interfacial Physics and Technology","award":["CASKL-IPT1702"],"award-info":[{"award-number":["CASKL-IPT1702"]}]},{"DOI":"10.13039\/501100012226","name":"Fundamental Research Funds for the Central Universities","doi-asserted-by":"publisher","award":["3290008414"],"award-info":[{"award-number":["3290008414"]}],"id":[{"id":"10.13039\/501100012226","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012226","name":"Fundamental Research Funds for the Central Universities","doi-asserted-by":"publisher","award":["3290008413"],"award-info":[{"award-number":["3290008413"]}],"id":[{"id":"10.13039\/501100012226","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Nanobiotechnol"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Pancreatic adenocarcinoma (PDAC) is one of the most fatal malignancies. Surgical resection supplemented by chemotherapy remains the major therapeutic regimen, but with unavoidable resistance and systemic toxic reaction. Curcumin is a known safe natural compound that can effectively eliminate pancreatic adenocarcinoma cells in vitro, making it a promising candidate for substitution in subsequent chemotherapy. However, due to its extremely low bioavailability caused by its insolubility and circular elimination, curcumin had an unexpectedly modest therapeutic effect in clinical trials.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Here, we electrospun curcumin\/gelatin-blended nanofibrous mat to largely improve curcumin\u2019s bioavailability by local controlled-release. With characterization by scanning electron microscopy, fluorescence microscopy, Fourier transform infrared spectroscopy, X-ray diffraction and high-performance liquid chromatography, it was revealed that curcumin was uniformly dispersed in the fiber of the mats with nanoscopic dimensions and could be continuously released into the surrounding medium for days. The cancer inhibitory effects of nano-curcumin and underlying mechanisms were further explored by assays using pancreatic adenocarcinoma cell and experiments using xenograft model. The results showed the released nano-curcumin could effectively inhibit pancreatic adenocarcinoma cell proliferation not only in vitro, but more importantly in vivo. This cytotoxic effect of nano-curcumin against pancreatic adenocarcinoma was achieved through provoking the production of intracellular reactive oxygen species and activating endoplasmic reticulum stress, which leads to enhanced cell apoptosis via decreased phosphorylation of signal transducer and activator of transcription 3.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Clinically, curcumin\/gelatin-blended nanofibrous mat could be a promising, secure, efficient and affordable substitutional agent for the elimination of residual cancer cells after tumor resection. Moreover, our strategy to obtain curcumin released from nanofibrous mat may provide a universally applicable approach for the study of the therapeutic effects and molecular mechanisms of other potential medicines with low bioavailability.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12951-020-00687-2","type":"journal-article","created":{"date-parts":[[2020,9,5]],"date-time":"2020-09-05T02:02:53Z","timestamp":1599271373000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":33,"title":["Topically applicated curcumin\/gelatin-blended nanofibrous mat inhibits pancreatic adenocarcinoma by increasing ROS production and endoplasmic reticulum stress mediated apoptosis"],"prefix":"10.1186","volume":"18","author":[{"given":"Tao","family":"Cheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiheng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziying","family":"Jian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junsheng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yujun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1679-9238","authenticated-orcid":false,"given":"Yi","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyi","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,9,5]]},"reference":[{"issue":"6","key":"687_CR1","doi-asserted-by":"crossref","first-page":"394","DOI":"10.3322\/caac.21492","volume":"68","author":"F Bray","year":"2018","unstructured":"Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394\u2013424.","journal-title":"CA Cancer J Clin"},{"issue":"2","key":"687_CR2","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1097\/MPA.0000000000000976","volume":"47","author":"X Jia","year":"2018","unstructured":"Jia X, Du P, Wu K, Xu Z, Fang J, Xu X, et al. Pancreatic cancer mortality in China: characteristics and prediction. Pancreas. 2018;47(2):233\u20137.","journal-title":"Pancreas"},{"issue":"1","key":"687_CR3","doi-asserted-by":"publisher","first-page":"10","DOI":"10.14740\/wjon1166","volume":"10","author":"P Rawla","year":"2019","unstructured":"Rawla P, Sunkara T, Gaduputi V. Epidemiology of pancreatic cancer: global trends, etiology and risk factors. World J Oncol. 2019;10(1):10\u201327.","journal-title":"World J Oncol"},{"issue":"43","key":"687_CR4","doi-asserted-by":"publisher","first-page":"4846","DOI":"10.3748\/wjg.v24.i43.4846","volume":"24","author":"A McGuigan","year":"2018","unstructured":"McGuigan A, Kelly P, Turkington RC, Jones C, Coleman HG, McCain RS. Pancreatic cancer: a review of clinical diagnosis, epidemiology, treatment and outcomes. World J Gastroenterol. 2018;24(43):4846\u201361.","journal-title":"World J Gastroenterol"},{"issue":"1","key":"687_CR5","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.pan.2014.10.001","volume":"15","author":"M Hidalgo","year":"2015","unstructured":"Hidalgo M, Cascinu S, Kleeff J, Labianca R, L\u00f6hr JM, Neoptolemos J, et al. Addressing the challenges of pancreatic cancer: future directions for improving outcomes. Pancreatology. 2015;15(1):8\u201318.","journal-title":"Pancreatology"},{"issue":"6","key":"687_CR6","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1002\/ags3.12203","volume":"2","author":"T Hackert","year":"2018","unstructured":"Hackert T. Surgery for pancreatic cancer after neoadjuvant treatment. Ann Gastroenterol Surg. 2018;2(6):413\u20138.","journal-title":"Ann Gastroenterol Surg"},{"issue":"11","key":"687_CR7","doi-asserted-by":"publisher","first-page":"3157","DOI":"10.3748\/wjg.v21.i11.3157","volume":"21","author":"D Ansari","year":"2015","unstructured":"Ansari D, Gustafsson A, Andersson R. Update on the management of pancreatic cancer: surgery is not enough. World J Gastroenterol. 2015;21(11):3157\u201365.","journal-title":"World J Gastroenterol"},{"issue":"1","key":"687_CR8","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1186\/s12957-017-1175-7","volume":"15","author":"S Dong","year":"2017","unstructured":"Dong S, Wang L, Guo YB, Ying HF, Shen XH, Meng ZQ, et al. Risk factors of liver metastasis from advanced pancreatic adenocarcinoma: a large multicenter cohort study. World J Surg Oncol. 2017;15(1):120.","journal-title":"World J Surg Oncol"},{"issue":"1","key":"687_CR9","first-page":"143","volume":"7","author":"A Dehal","year":"2016","unstructured":"Dehal A, Smith JJ, Nash GM. Cytoreductive surgery and intraperitoneal chemotherapy: an evidence-based review-past, present and future. J Gastrointest Oncol. 2016;7(1):143\u201357.","journal-title":"J Gastrointest Oncol"},{"issue":"1","key":"687_CR10","doi-asserted-by":"publisher","first-page":"e186847","DOI":"10.1001\/jamanetworkopen.2018.6847","volume":"2","author":"JM Foster","year":"2019","unstructured":"Foster JM, Sleightholm R, Patel A, Shostrom V, Hall B, Neilsen B, et al. Morbidity and mortality rates following cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy compared with other high-risk surgical oncology procedures. JAMA Netw Open. 2019;2(1):e186847.","journal-title":"JAMA Netw Open"},{"issue":"3","key":"687_CR11","doi-asserted-by":"publisher","first-page":"307","DOI":"10.2478\/raon-2018-0030","volume":"52","author":"B Kobal","year":"2018","unstructured":"Kobal B, Noventa M, Cvjeticanin B, Barbic M, Meglic L, Herzog M, et al. Primary debulking surgery versus primary neoadjuvant chemotherapy for high grade advanced stage ovarian cancer: comparison of survivals. Radiol Oncol. 2018;52(3):307\u201319.","journal-title":"Radiol Oncol"},{"issue":"30","key":"687_CR12","doi-asserted-by":"publisher","first-page":"6906","DOI":"10.3748\/wjg.v22.i30.6906","volume":"22","author":"Y Li","year":"2016","unstructured":"Li Y, Zhou Y-F, Liang H, Wang H-Q, Hao J-H, Zhu Z-G, et al. Chinese expert consensus on cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal malignancies. World J Gastroenterol. 2016;22(30):6906\u201316.","journal-title":"World J Gastroenterol"},{"issue":"6","key":"687_CR13","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1177\/000313481307900624","volume":"79","author":"RW Randle","year":"2013","unstructured":"Randle RW, Swett KR, Shen P, Stewart JH, Levine EA, Votanopoulos KI. Cytoreductive surgery with hyperthermic intraperitoneal chemotherapy in peritoneal sarcomatosis. Am Surg. 2013;79(6):620\u20134.","journal-title":"Am Surg"},{"issue":"3","key":"687_CR14","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1055\/s-2005-916281","volume":"18","author":"PH Sugarbaker","year":"2005","unstructured":"Sugarbaker PH. Cytoreductive surgery and perioperative intraperitoneal chemotherapy: a new standard of care for appendiceal mucinous tumors with peritoneal dissemination. Clin Colon Rectal Surg. 2005;18(3):204\u201314.","journal-title":"Clin Colon Rectal Surg"},{"issue":"1","key":"687_CR15","first-page":"29","volume":"7","author":"PH Sugarbaker","year":"2016","unstructured":"Sugarbaker PH, Van der Speeten K. Surgical technology and pharmacology of hyperthermic perioperative chemotherapy. J Gastrointest Oncol. 2016;7(1):29\u201344.","journal-title":"J Gastrointest Oncol"},{"issue":"2","key":"687_CR16","first-page":"482","volume":"23","author":"AA Tentes","year":"2018","unstructured":"Tentes AA, Pallas N, Karamveri C, Kyziridis D, Hristakis C. Cytoreduction and HIPEC for peritoneal carcinomatosis of pancreatic cancer. J Balkan Union Oncol. 2018;23(2):482\u20137.","journal-title":"J Balkan Union Oncol"},{"issue":"8","key":"687_CR17","doi-asserted-by":"publisher","first-page":"26","DOI":"10.21037\/apc.2018.08.02","volume":"1","author":"AR Wolfe","year":"2018","unstructured":"Wolfe AR, Williams TM. Altering the response to radiation: radiosensitizers and targeted therapies in pancreatic ductal adenocarcinoma: preclinical and emerging clinical evidence. Ann Pancreat Cancer. 2018;1(8):26.","journal-title":"Ann Pancreat Cancer"},{"key":"687_CR18","doi-asserted-by":"publisher","first-page":"105967","DOI":"10.1016\/j.intimp.2019.105967","volume":"77","author":"C Bailly","year":"2019","unstructured":"Bailly C. Potential use of edaravone to reduce specific side effects of chemo-, radio- and immuno-therapy of cancers. Int Immunopharmacol. 2019;77:105967.","journal-title":"Int Immunopharmacol"},{"issue":"11","key":"687_CR19","first-page":"523","volume":"109","author":"M Cascella","year":"2018","unstructured":"Cascella M, Di Napoli R, Carbone D, Cuomo GF, Bimonte S, Muzio MR. Chemotherapy-related cognitive impairment: mechanisms, clinical features and research perspectives. Recenti Prog Med. 2018;109(11):523\u201330.","journal-title":"Recenti Prog Med"},{"issue":"2","key":"687_CR20","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1158\/2159-8290.CD-16-0241","volume":"7","author":"M Demaria","year":"2017","unstructured":"Demaria M, Leary MN, Chang J, Shao L, Liu S, Alimirah F, et al. Cellular senescence promotes adverse effects of chemotherapy and cancer relapse. Cancer Discov. 2017;7(2):165.","journal-title":"Cancer Discov"},{"issue":"1","key":"687_CR21","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1002\/jso.23137","volume":"107","author":"KA Goodman","year":"2013","unstructured":"Goodman KA, Hajj C. Role of radiation therapy in the management of pancreatic cancer. J Surg Oncol. 2013;107(1):86\u201396.","journal-title":"J Surg Oncol"},{"key":"687_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.freeradbiomed.2016.12.007","volume":"103","author":"GS Kaplan","year":"2017","unstructured":"Kaplan GS, Torcun CC, Grune T, Ozer NK, Karademir B. Proteasome inhibitors in cancer therapy: treatment regimen and peripheral neuropathy as a side effect. Free Radic Biol Med. 2017;103:1\u201313.","journal-title":"Free Radic Biol Med"},{"issue":"2","key":"687_CR23","first-page":"115","volume":"8","author":"K Metri","year":"2013","unstructured":"Metri K, Bhargav H, Chowdhury P, Koka PS. Ayurveda for chemo-radiotherapy induced side effects in cancer patients. J Stem Cells. 2013;8(2):115\u201329.","journal-title":"J Stem Cells"},{"issue":"7","key":"687_CR24","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1038\/nrd4003","volume":"12","author":"EJ Moding","year":"2013","unstructured":"Moding EJ, Kastan MB, Kirsch DG. Strategies for optimizing the response of cancer and normal tissues to radiation. Nat Rev Drug Discov. 2013;12(7):526\u201342.","journal-title":"Nat Rev Drug Discov"},{"issue":"19","key":"687_CR25","doi-asserted-by":"publisher","first-page":"6645","DOI":"10.1039\/C8DT00838H","volume":"47","author":"R Oun","year":"2018","unstructured":"Oun R, Moussa YE, Wheate NJ. The side effects of platinum-based chemotherapy drugs: a review for chemists. Dalton Trans. 2018;47(19):6645\u201353.","journal-title":"Dalton Trans"},{"issue":"3","key":"687_CR26","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/j.rpor.2020.03.007","volume":"25","author":"MK Ramirez-Fort","year":"2020","unstructured":"Ramirez-Fort MK, Rogers MJ, Santiago R, Mahase SS, Mendez M, Zheng Y, et al. Prostatic irradiation-induced sexual dysfunction: a review and multidisciplinary guide to management in the radical radiotherapy era (Part I defining the organ at risk for sexual toxicities). Rep Pract Oncol Radiother. 2020;25(3):367\u201375.","journal-title":"Rep Pract Oncol Radiother"},{"key":"687_CR27","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1007\/978-3-319-40389-2_5","volume":"170","author":"SS Sampath","year":"2016","unstructured":"Sampath SS. Treatment: radiation therapy. Cancer Treat Res. 2016;170:105\u201318.","journal-title":"Cancer Treat Res"},{"key":"687_CR28","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1007\/s00384-020-03595-x","volume":"35","author":"A Sipaviciute","year":"2020","unstructured":"Sipaviciute A, Sileika E, Burneckis A, Dulskas A. Late gastrointestinal toxicity after radiotherapy for rectal cancer: a systematic review. Int J Colorectal Dis. 2020;35:977\u201383.","journal-title":"Int J Colorectal Dis"},{"issue":"1","key":"687_CR29","doi-asserted-by":"publisher","first-page":"e186839","DOI":"10.1001\/jamanetworkopen.2018.6839","volume":"2","author":"ME Smith","year":"2019","unstructured":"Smith ME, Nathan H. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: safety is only half of the story. JAMA Netw Open. 2019;2(1):e186839.","journal-title":"JAMA Netw Open"},{"key":"687_CR30","doi-asserted-by":"publisher","first-page":"5011","DOI":"10.1007\/s00330-020-06843-4","volume":"30","author":"J Wei","year":"2020","unstructured":"Wei J, Shen Z, Wang H, Zhao Q, Ji R, Wang B, et al. Research progress on mechanism and dosimetry of brainstem injury induced by intensity-modulated radiotherapy, proton therapy, and heavy ion radiotherapy. Eur Radiol. 2020;30:5011\u201320.","journal-title":"Eur Radiol"},{"issue":"5","key":"687_CR31","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1517\/14740338.2013.795944","volume":"12","author":"G Alatrash","year":"2013","unstructured":"Alatrash G, Jakher H, Stafford PD, Mittendorf EA. Cancer immunotherapies, their safety and toxicity. Expert Opin Drug Saf. 2013;12(5):631\u201345.","journal-title":"Expert Opin Drug Saf"},{"issue":"7","key":"687_CR32","doi-asserted-by":"publisher","first-page":"A624","DOI":"10.1016\/j.jval.2016.09.1600","volume":"19","author":"NR Bhandari","year":"2016","unstructured":"Bhandari NR, Kathe NJ, Martin BC. Cost of healthcare among metastatic lung cancer patients receiving chemotherapy. Value Health. 2016;19(7):A624\u2013A625625.","journal-title":"Value Health"},{"key":"687_CR33","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.critrevonc.2018.07.002","volume":"129","author":"CRP da Veiga","year":"2018","unstructured":"da Veiga CRP, da Veiga CP, Drummond-Lage AP. Concern over cost of and access to cancer treatments: a meta-narrative review of nivolumab and pembrolizumab studies. Crit Rev Oncol\/Hematol. 2018;129:133\u201345.","journal-title":"Crit Rev Oncol\/Hematol"},{"issue":"15_suppl","key":"687_CR34","doi-asserted-by":"publisher","first-page":"e18225","DOI":"10.1200\/JCO.2019.37.15_suppl.e18225","volume":"37","author":"DW Dougherty","year":"2019","unstructured":"Dougherty DW, Leblebjian H, Duperrault M, Awad MM, Bartel S, McDonnell A, et al. Outcomes of immunotherapy administration for hospitalized cancer patients. J Clin Oncol. 2019;37(15_suppl):e18225.","journal-title":"J Clin Oncol"},{"issue":"3","key":"687_CR35","doi-asserted-by":"publisher","first-page":"S312","DOI":"10.1016\/j.bbmt.2019.12.389","volume":"26","author":"AH Harris","year":"2020","unstructured":"Harris AH, Hohmann S, Dolan C. Real-world quality and cost burden of cytokine release syndrome requiring tocilizumab or steroids during CAR-T infusion encounter. Biol Blood Marrow Transpl. 2020;26(3):S312.","journal-title":"Biol Blood Marrow Transpl"},{"issue":"1","key":"687_CR36","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1182\/asheducation-2018.1.25","volume":"2018","author":"T Jain","year":"2018","unstructured":"Jain T, Litzow MR. No free rides: management of toxicities of novel immunotherapies in ALL, including financial. Hematol Am Soc Hematol Edu Progr. 2018;2018(1):25\u201334.","journal-title":"Hematol Am Soc Hematol Edu Progr"},{"issue":"1","key":"687_CR37","first-page":"112","volume":"7","author":"LA Lambert","year":"2016","unstructured":"Lambert LA, Harris A. Palliative cytoreductive surgery and hyperthermic intraperitoneal chemoperfusion: current clinical practice or misnomer? J Gastrointest Oncol. 2016;7(1):112\u201321.","journal-title":"J Gastrointest Oncol"},{"issue":"9","key":"687_CR38","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1080\/13696998.2016.1184155","volume":"19","author":"K Vouk","year":"2016","unstructured":"Vouk K, Benter U, Amonkar MM, Marocco A, Stapelkamp C, Pfersch S, et al. Cost and economic burden of adverse events associated with metastatic melanoma treatments in five countries. J Med Econ. 2016;19(9):900\u201312.","journal-title":"J Med Econ"},{"issue":"10","key":"687_CR39","doi-asserted-by":"publisher","first-page":"13017","DOI":"10.1007\/s13277-016-5183-y","volume":"37","author":"PD Kasi","year":"2016","unstructured":"Kasi PD, Tamilselvam R, Skalicka-Wo\u017aniak K, Nabavi SF, Daglia M, Bishayee A, et al. Molecular targets of curcumin for cancer therapy: an updated review. Tumor Biol. 2016;37(10):13017\u201328.","journal-title":"Tumor Biol"},{"issue":"11","key":"687_CR40","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.1111\/bph.13621","volume":"174","author":"AB Kunnumakkara","year":"2017","unstructured":"Kunnumakkara AB, Bordoloi D, Padmavathi G, Monisha J, Roy NK, Prasad S, et al. Curcumin, the golden nutraceutical: multitargeting for multiple chronic diseases. Br J Pharmacol. 2017;174(11):1325\u201348.","journal-title":"Br J Pharmacol"},{"key":"687_CR41","first-page":"1","volume-title":"Reviews of physiology, biochemistry and pharmacology","author":"AA Momtazi","year":"2016","unstructured":"Momtazi AA, Shahabipour F, Khatibi S, Johnston TP, Pirro M, Sahebkar A. Curcumin as a MicroRNA regulator in cancer: a review. In: Nilius B, de Tombe P, Gudermann T, Jahn R, Lill R, Petersen OH, editors. Reviews of physiology, biochemistry and pharmacology, vol. 171. Cham: Springer International Publishing; 2016. p. 1\u201338."},{"issue":"5","key":"687_CR42","doi-asserted-by":"publisher","first-page":"1620","DOI":"10.1021\/acs.jmedchem.6b00975","volume":"60","author":"KM Nelson","year":"2017","unstructured":"Nelson KM, Dahlin JL, Bisson J, Graham J, Pauli GF, Walters MA. The essential medicinal chemistry of curcumin. J Med Chem. 2017;60(5):1620\u201337.","journal-title":"J Med Chem"},{"issue":"1","key":"687_CR43","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.canlet.2015.11.021","volume":"371","author":"J-A Seo","year":"2016","unstructured":"Seo J-A, Kim B, Dhanasekaran DN, Tsang BK, Song YS. Curcumin induces apoptosis by inhibiting sarco\/endoplasmic reticulum Ca2+ ATPase activity in ovarian cancer cells. Cancer Lett. 2016;371(1):30\u20137.","journal-title":"Cancer Lett"},{"issue":"9","key":"687_CR44","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1080\/17425255.2017.1360279","volume":"13","author":"J Adiwidjaja","year":"2017","unstructured":"Adiwidjaja J, McLachlan AJ, Boddy AV. Curcumin as a clinically-promising anti-cancer agent: pharmacokinetics and drug interactions. Expert Opin Drug Metab Toxicol. 2017;13(9):953\u201372.","journal-title":"Expert Opin Drug Metab Toxicol"},{"issue":"4b","key":"687_CR45","first-page":"2895","volume":"21","author":"AL Cheng","year":"2001","unstructured":"Cheng AL, Hsu CH, Lin JK, Hsu MM, Ho YF, Shen TS, et al. Phase I clinical trial of curcumin, a chemopreventive agent, in patients with high-risk or pre-malignant lesions. Anticancer Res. 2001;21(4b):2895\u2013900.","journal-title":"Anticancer Res"},{"issue":"14","key":"687_CR46","doi-asserted-by":"publisher","first-page":"4491","DOI":"10.1158\/1078-0432.CCR-08-0024","volume":"14","author":"N Dhillon","year":"2008","unstructured":"Dhillon N, Aggarwal BB, Newman RA, Wolff RA, Kunnumakkara AB, Abbruzzese JL, et al. Phase II trial of curcumin in patients with advanced pancreatic cancer. Clin Cancer Res. 2008;14(14):4491\u20139.","journal-title":"Clin Cancer Res"},{"issue":"7","key":"687_CR47","doi-asserted-by":"publisher","first-page":"1634","DOI":"10.1002\/jcb.25897","volume":"118","author":"M Hosseini","year":"2017","unstructured":"Hosseini M, Hassanian SM, Mohammadzadeh E, ShahidSales S, Maftouh M, Fayazbakhsh H, et al. Therapeutic potential of curcumin in treatment of pancreatic cancer: current status and future perspectives. J Cell Biochem. 2017;118(7):1634\u20138.","journal-title":"J Cell Biochem"},{"issue":"8","key":"687_CR48","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1080\/01635581.2010.513802","volume":"62","author":"R Epelbaum","year":"2010","unstructured":"Epelbaum R, Schaffer M, Vizel B, Badmaev V, Bar-Sela G. Curcumin and gemcitabine in patients with advanced pancreatic cancer. Nutr Cancer. 2010;62(8):1137\u201341.","journal-title":"Nutr Cancer"},{"issue":"7","key":"687_CR49","first-page":"1894","volume":"7","author":"RA Sharma","year":"2001","unstructured":"Sharma RA, McLelland HR, Hill KA, Ireson CR, Euden SA, Manson MM, et al. Pharmacodynamic and pharmacokinetic study of oral Curcuma extract in patients with colorectal cancer. Clin Cancer Res. 2001;7(7):1894\u2013900.","journal-title":"Clin Cancer Res"},{"key":"687_CR50","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/1472-6882-6-10","volume":"6","author":"CD Lao","year":"2006","unstructured":"Lao CD, Ruffin MT, Normolle D, Heath DD, Murray SI, Bailey JM, et al. Dose escalation of a curcuminoid formulation. BMC Complement Altern Med. 2006;6:10.","journal-title":"BMC Complement Altern Med"},{"issue":"6","key":"687_CR51","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1097\/CAD.0b013e32832afc04","volume":"20","author":"L Friedman","year":"2009","unstructured":"Friedman L, Lin L, Ball S, Bekaii-Saab T, Fuchs J, Li PK, et al. Curcumin analogues exhibit enhanced growth suppressive activity in human pancreatic cancer cells. Anticancer Drugs. 2009;20(6):444\u20139.","journal-title":"Anticancer Drugs"},{"issue":"1","key":"687_CR52","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1002\/ijc.31867","volume":"145","author":"GP Nagaraju","year":"2019","unstructured":"Nagaraju GP, Benton L, Bethi SR, Shoji M, El-Rayes BF. Curcumin analogs: their roles in pancreatic cancer growth and metastasis. Int J Cancer. 2019;145(1):10\u20139.","journal-title":"Int J Cancer"},{"issue":"3","key":"687_CR53","doi-asserted-by":"publisher","first-page":"e368","DOI":"10.1038\/am.2017.31","volume":"9","author":"X Dai","year":"2017","unstructured":"Dai X, Liu J, Zheng H, Wichmann J, Hopfner U, Sudhop S, et al. Nano-formulated curcumin accelerates acute wound healing through Dkk-1-mediated fibroblast mobilization and MCP-1-mediated anti-inflammation. NPG Asia Mater. 2017;9(3):e368.","journal-title":"NPG Asia Mater"},{"issue":"10","key":"687_CR54","doi-asserted-by":"publisher","first-page":"1582","DOI":"10.1016\/j.drudis.2017.07.001","volume":"22","author":"C Mohanty","year":"2017","unstructured":"Mohanty C, Sahoo SK. Curcumin and its topical formulations for wound healing applications. Drug Discov Today. 2017;22(10):1582\u201392.","journal-title":"Drug Discov Today"},{"issue":"4","key":"687_CR55","doi-asserted-by":"publisher","first-page":"522","DOI":"10.3390\/polym2040522","volume":"2","author":"SA Sell","year":"2010","unstructured":"Sell SA, Wolfe PS, Garg K, McCool JM, Rodriguez IA, Bowlin GL. The use of natural polymers in tissue engineering: a focus on electrospun extracellular matrix analogues. Polymers. 2010;2(4):522\u201353.","journal-title":"Polymers"},{"issue":"4","key":"687_CR56","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1136\/gutjnl-2014-307616","volume":"65","author":"B Kong","year":"2016","unstructured":"Kong B, Wu W, Cheng T, Schlitter AM, Qian C, Bruns P, et al. A subset of metastatic pancreatic ductal adenocarcinomas depends quantitatively on oncogenic Kras\/Mek\/Erk-induced hyperactive mTOR signalling. Gut. 2016;65(4):647.","journal-title":"Gut"},{"key":"687_CR57","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1007\/978-3-319-40400-4_14","volume-title":"Pharmacovigilance: critique and ways forward","author":"S Skalli","year":"2017","unstructured":"Skalli S, Jordan SA. Herbal and traditional medicines, now and future. In: Edwards IR, Lindquist M, editors. Pharmacovigilance: critique and ways forward. Cham: Springer International Publishing; 2017. p. 145\u2013159."},{"key":"687_CR58","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/B978-0-323-55512-8.00025-9","volume-title":"Hunter's tropical medicine and emerging infectious diseases","author":"G Bodeker","year":"2020","unstructured":"Bodeker G, Graz B. 25\u2014Traditional medicine. In: Ryan ET, Hill DR, Solomon T, Aronson NE, Endy TP, editors. Hunter's tropical medicine and emerging infectious diseases. 10th ed. London: Elsevier; 2020. p. 194\u2013199.","edition":"10"},{"issue":"35","key":"687_CR59","doi-asserted-by":"publisher","first-page":"10210","DOI":"10.1002\/anie.201601967","volume":"55","author":"Y Tu","year":"2016","unstructured":"Tu Y. Artemisinin\u2014a gift from traditional Chinese medicine to the world (Nobel Lecture). Angew Chem Int Ed. 2016;55(35):10210\u201326.","journal-title":"Angew Chem Int Ed"},{"issue":"5","key":"687_CR60","doi-asserted-by":"publisher","first-page":"559","DOI":"10.3390\/molecules21050559","volume":"21","author":"H Yuan","year":"2016","unstructured":"Yuan H, Ma Q, Ye L, Piao G. The traditional medicine and modern medicine from natural products. Molecules. 2016;21(5):559.","journal-title":"Molecules"},{"key":"687_CR61","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.1016\/j.msec.2017.03.226","volume":"77","author":"Z Hussain","year":"2017","unstructured":"Hussain Z, Thu HE, Amjad MW, Hussain F, Ahmed TA, Khan S. Exploring recent developments to improve antioxidant, anti-inflammatory and antimicrobial efficacy of curcumin: a review of new trends and future perspectives. Mater Sci Eng C. 2017;77:1316\u201326.","journal-title":"Mater Sci Eng C"},{"issue":"4","key":"687_CR62","doi-asserted-by":"publisher","first-page":"1623","DOI":"10.1007\/s00204-017-1939-4","volume":"91","author":"F Ullah","year":"2017","unstructured":"Ullah F, Liang A, Rangel A, Gyengesi E, Niedermayer G, M\u00fcnch G. High bioavailability curcumin: an anti-inflammatory and neurosupportive bioactive nutrient for neurodegenerative diseases characterized by chronic neuroinflammation. Arch Toxicol. 2017;91(4):1623\u201334.","journal-title":"Arch Toxicol"},{"issue":"6","key":"687_CR63","doi-asserted-by":"publisher","first-page":"4497","DOI":"10.1002\/jcp.26249","volume":"233","author":"F Keihanian","year":"2018","unstructured":"Keihanian F, Saeidinia A, Bagheri RK, Johnston TP, Sahebkar A. Curcumin, hemostasis, thrombosis, and coagulation. J Cell Physiol. 2018;233(6):4497\u2013511.","journal-title":"J Cell Physiol"},{"issue":"3","key":"687_CR64","doi-asserted-by":"publisher","first-page":"264","DOI":"10.3390\/molecules21030264","volume":"21","author":"M Pulido-Moran","year":"2016","unstructured":"Pulido-Moran M, Moreno-Fernandez J, Ramirez-Tortosa C, Ramirez-Tortosa M. Curcumin and health. Molecules. 2016;21(3):264.","journal-title":"Molecules"},{"key":"687_CR65","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.biopha.2016.11.098","volume":"85","author":"H Mirzaei","year":"2017","unstructured":"Mirzaei H, Shakeri A, Rashidi B, Jalili A, Banikazemi Z, Sahebkar A. Phytosomal curcumin: a review of pharmacokinetic, experimental and clinical studies. Biomed Pharmacother. 2017;85:102\u201312.","journal-title":"Biomed Pharmacother"},{"issue":"7636","key":"687_CR66","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1038\/541144a","volume":"541","author":"M Baker","year":"2017","unstructured":"Baker M. Deceptive curcumin offers cautionary tale for chemists. Nature. 2017;541(7636):144\u20135.","journal-title":"Nature"},{"issue":"2","key":"687_CR67","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.canlet.2008.03.009","volume":"269","author":"AB Kunnumakkara","year":"2008","unstructured":"Kunnumakkara AB, Anand P, Aggarwal BB. Curcumin inhibits proliferation, invasion, angiogenesis and metastasis of different cancers through interaction with multiple cell signaling proteins. Cancer Lett. 2008;269(2):199\u2013225.","journal-title":"Cancer Lett"}],"container-title":["Journal of Nanobiotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-020-00687-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12951-020-00687-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-020-00687-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,17]],"date-time":"2022-04-17T18:06:25Z","timestamp":1650218785000},"score":1,"resource":{"primary":{"URL":"https:\/\/jnanobiotechnology.biomedcentral.com\/articles\/10.1186\/s12951-020-00687-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,5]]},"references-count":67,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["687"],"URL":"https:\/\/doi.org\/10.1186\/s12951-020-00687-2","relation":{},"ISSN":["1477-3155"],"issn-type":[{"value":"1477-3155","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9,5]]},"assertion":[{"value":"3 June 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 August 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 September 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was approved by the Institutional Animal Care and Use Committee of Shanghai Jiao Tong University (Document number: 2020038).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"126"}}